Insulet Corporation

NASDAQ:PODD

Medical - Devices

Healthcare
$139.98 -2.82%

-$4.17 today

Market cap
$9.71B
Beta
1.13
P/E (TTM)
33.2
EPS (TTM)
$4.33
52W Low $140.63High $354.88

Volume 2.09M

Average 1.32M

PODD Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Insulet CorporationNASDAQ: PODD

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 70.2%

Gross margin was 70.2% in Q2 FY2026, up 0.5 pp from a year earlier. On a trailing-twelve-month basis it was 71.1%, up 0.3 pp year over year. Over 3 fiscal years it widened by 9.9 pp.

Context

  • Gross margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
70.2%+0.7 pp QoQ
Last fiscal yearDec 2025
71.6%+1.8 pp YoY
LTMJun 2026
71.1%+0.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.5 pp——
1 year+1.8 pp——
3 years+9.9 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
71.6%
Year-over-year change
+1.8pp

Gross Margin vs competitors

How PODD compares with its peers on the latest reported figures

  • PODD's LTM Jun 2026 gross margin of 71.1% is the highest of the 5 companies compared; the peer median is 56.0%.
  • Its year-over-year change of +0.3 pp is the lowest of 5, against a peer median of +6.0 pp.
  • Over three fiscal years its change of +9.9 pp compares with a peer median of -1.9 pp.
PODD Competitors Peer median
Gross Margin for PODD and competitors
Company Period LTM level YoY 3-year change
PODDInsulet CorporationLTM Jun 202671.1% +0.3 pp+9.9 pp
DXCMDexCom, Inc.LTM Jun 202662.5% +3.7 pp-4.6 pp
BBNXBeta Bionics, Inc.LTM Mar 202657.2% +3.2 pp-44.6 pp
TNDMTandem Diabetes Care, Inc.LTM Mar 202654.9% +8.4 pp+0.8 pp
SENSSenseonics Holdings, Inc.LTM Mar 202652.1% +44.9 pp+28.1 pp
Peer median (excluding PODD) 56.0%+6.0 pp-1.9 pp

Competitors are the stored peer set for PODD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.1B1.31B1.7B2.07B2.71B
Cost of Revenue346.7M499.7M537.2M625.9M768.2M
Gross Profit752.1M805.6M1.16B1.45B1.94B
Gross Margin68.4%61.7%68.3%69.8%71.6%
Research & Development160.1M180.2M205M219.6M301.1M
Selling, General & Admin466M587.8M734.9M917.2M1.17B
Operating Expenses626.1M768M939.9M1.14B1.47B
Depreciation & Amortization57.4M63.2M72.8M80.8M90.4M
EBITDA139.6M109M323.6M423.7M509.6M
EBITDA Margin12.7%8.4%19.1%20.5%18.8%
Operating Income126M37.6M220M308.9M473.8M
Operating Margin11.5%2.9%13.0%14.9%17.5%
Interest Income500K9.3M28.6M39.5M34.7M
Interest Expense61.7M36M36.2M42.7M79.7M
Other Income / Expenses(105.5M)(27.8M)(5.4M)(8.7M)(134.3M)
Income Before Tax20.5M9.8M214.6M300.2M339.5M
Pre-Tax Margin1.9%0.8%12.6%14.5%12.5%
Income Tax Expense3.7M5.2M8.3M(118.1M)92.4M
Net Income16.8M4.6M206.3M418.3M247.1M
Net Margin1.5%0.4%12.2%20.2%9.1%
EPS (Basic)0.250.072.965.973.51
EPS (Diluted)0.250.072.945.783.48
Weighted Avg Shares67.7M69.38M69.75M70.08M70.35M
Weighted Avg Shares (Diluted)68.58M69.91M73.63M73.89M71.89M

Insulet Corporation

NASDAQ:PODD

Intrinsic Alpha fair value

Locked

Current Price

$139.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.